|
Enterprises by main area of activity in biotechnology
|
P3269
|
|
| 2011-2024 | Region (NUTS 2) | 24 |
The areas of activity in biotechnology- Human health (with and without rDNA technology) - Human health (with rDNA technology) large molecule therapeutics and monoclonal antibodies produced using rDNA technology, - Human health (without rDNA technology) other therapeutics, artificial substrates, diagnostics and drug delivery technologies, etc., - Veterinary health diagnostics, vaccination and medical treatment of animals, - GM agriculture new varieties of genetically modified (GM) plants, animals and micro-organisms, - Non-GM agriculture new varieties of non-GM plants, animals and micro-organisms developed using biotechnology techniques, bio-pest controls, etc., - Natural resources mining, petroleum/energy extraction , etc., - Environment diagnostics, bioremediation, waste disposal, clean production, etc., - Industrial processing food, cosmetics, fuels, chemicals (e.g. enzymes), plastics, etc., - Bioinformatics- creating genomic/protein databases, modeling biotechnological complex processes, systems biology, - Non-specific applications research tools, - Other. The main (dominant) area of operations in the field of biotechnology: indicated by an area of application of biotechnology techniques, which incurred the greatest costs or generating the most revenue from the sale of biotechnology products.
|
|
Enterprises conducting biotechnology activities
|
P3265
|
|
| 2011-2024 | Region (NUTS 2) | 4 |
Enterprise operating in biotechnology (biotechnology firm) - an enterprise that uses one or more techniques of biotechnology (as defined biotechnology) for the production of goods or services and / or to carry out systematic research and development (R & D) in order to increase the resources knowledge and its economic applications.
|
|
Internal biotechnology personnel in enterprises
|
P3268
|
|
| 2011-2024 | Region (NUTS 2) | 4 |
Employment in research and development (R & D) in biotechnology- Employees spending at least 10% of their working time are counted as R&D employees. Full-time equivalents - FTE- conversion units used to determine actual employment in R&D. One full-time equivalent (FTE) means one person-year devoted exclusively to R&D activities. Employment in R&D in full-time equivalents is calculated on the basis of the ratio of working time devoted to R&D by particular employees within a reporting year to full working time on a particulate position in a given institution.
|
|
Internal biotechnology research and development (R&D) personnel in scientific units
|
P3262
|
|
| 2011-2024 | Region (NUTS 2) | 4 |
Persons employed in research and development (R & D) in biotechnology- Employees spending at least 10% of their working time are counted as R&D employees. Full-time equivalents - FTE- conversion units used to determine actual employment in R&D. One full-time equivalent (FTE) means one person-year devoted exclusively to R&D activities. Employment in R&D in full-time equivalents is calculated on the basis of the ratio of working time devoted to R&D by particular employees within a reporting year to full working time on a particulate position in a given institution.
|
|
Internal biotechnology research and development (R&D) personnel in scientific units by level of education
|
P3263
|
|
| 2011-2024 | Region (NUTS 2) | 6 |
Employment in research and development (R & D) in biotechnology - Employees spending at least 10% of their working time are counted as R&D employees.
|